Non-HDL cholesterol ≤100 mg/dL

Biomarker

3 findings

“Those with non-HDL-C level ≤100 mg/dL had median fatty plaque regression of 18.8% [IQR: 6.9, 30.8] compared to median progression of 9.0%”
The Association between Non-High-Density Lipoprotein Cholesterol Level and Coronary Fatty Plaque RegressionAHA Scientific Sessions 2025 abstract2025doi:10.1161/circ.152.suppl_3.4367078

Effects

1

Coronary fatty plaque regression

upin humans1

1 study
  1. Non-HDL cholesterol ≤100 mg/dL improves coronary fatty plaque regression in humans (CAD with well-controlled hypertension on statin therapy (control group)) (median regression 18.8% vs 9.0% progression).

    “Those with non-HDL-C level ≤100 mg/dL had median fatty plaque regression of 18.8% [IQR: 6.9, 30.8] compared to median progression of 9.0%”

    Human trialCAD with well-controlled hypertension on statin therapy (control group)coronary artery30 monthsn = 53

    The Association between Non-High-Density Lipoprotein Cholesterol Level and Coronary Fatty Plaque Regression

    AHA Scientific Sessions 2025 abstract

Associations

2

Fibrinogen

upin humans1

1 study
  1. Non-HDL cholesterol ≤100 mg/dL is associated with fibrinogen in humans (CAD with well-controlled hypertension on statin therapy (control group)) (p=0.005).

    “Those with non-HDL-C level >100 mg/dL had significantly higher levels of inflammatory markers: neutrophil count (p=0.047) and fibrinogen level (p=0.005)”

    Human trialCAD with well-controlled hypertension on statin therapy (control group)30 monthsn = 53

    The Association between Non-High-Density Lipoprotein Cholesterol Level and Coronary Fatty Plaque Regression

    AHA Scientific Sessions 2025 abstract

More on Fibrinogen

Neutrophil count

upin humans1

1 study
  1. Non-HDL cholesterol ≤100 mg/dL is associated with neutrophil count in humans (CAD with well-controlled hypertension on statin therapy (control group)) (p=0.047).

    “Those with non-HDL-C level >100 mg/dL had significantly higher levels of inflammatory markers: neutrophil count (p=0.047) and fibrinogen level (p=0.005)”

    Human trialCAD with well-controlled hypertension on statin therapy (control group)30 monthsn = 53

    The Association between Non-High-Density Lipoprotein Cholesterol Level and Coronary Fatty Plaque Regression

    AHA Scientific Sessions 2025 abstract

More on Neutrophil count